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Telehealth has the potential to offer more convenient care and reduce travel.  We aimed to 
systematically review studies that assessed the effectiveness of teleconsultation plus telemonitoring in 
the review of people with Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) receiving 




Following Cochrane methodology, we searched 11 electronic databases (November 2015), trial 
registries, and reference lists of included studies, for trials testing interventions that combined remote 
consultations with telemonitoring of usage/CPAP data. Outcomes measures were: proportion reviewed, 




From 362 potentially relevant papers, we identified five RCTs (n=269 patients): four from North America 
and one from Spain. Risk of bias was moderate in one, and moderate/high in four trials.   Two trials 
reported number/duration of reviews with inconsistent results.  The teleconsultation/telemonitoring 
improved CPAP adherence in two trials (n=19; n=75); two (n= 114 and n=75) reported no between-
groups differences. Two studies, both at moderate/high risk of bias, showed no between-group 
difference in the Epworth Sleepiness Score.  Satisfaction was generally reported positively in all five 
trials; one trial reported that the teleconsultation/telemonitoring patients were ‘more likely to continue’ 




The evidence for teleconsultation/telemonitoring in CPAP users is limited; however no safety concerns 
have been raised.  Adequately powered, well-designed trials are needed to establish whether real time 
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Obstructive Sleep Apnoea hypopnoea Syndrome (OSAHS) is a major public health concern and an 
important cause of morbidity and mortality. (1-7) Epidemiological data reports its prevalence as 3–7% of 
middle-aged men and 2–5% of women. (2, 4) Globally, prevalence rates are increasing and this is directly 
related to obesity (2, 8, 9) though a minority of individuals are non-obese. (2, 10, 11) Other contributory 
factors are; enlarged tongue /tonsillar tissue, excess pharyngeal soft tissue and retro- or micro-gnathia. 
(12, 13) Quality of life (QoL) is adversely affected. (2, 7) The symptomatic consequences of OSAHS 
include; excessive daytime sleepiness, loud and socially disruptive snoring, nocturnal choking or gasping, 
poor unrefreshing sleep, mood changes, impaired alertness (sometimes when driving), morning 
headaches, nocturia and decreased libido. (2, 8, 11, 13, 14)  Driving-related accidents are a particular 
concern. (1) Work-related performance issues are common, and include incidents or accidents that may 
result in loss of employment. (1, 7) The increased prevalence of OSAHS in the last two decades has seen 
an exponential rise in referral rates for investigation and treatment of this condition. (2, 15)  
 
After diagnosis the majority of individuals are established on fixed CPAP therapy (usually following auto-
titration to establish therapeutic pressure settings). CPAP can improve morbidity and current guidelines 
recommend that patients using CPAP should be reviewed regularly to assess adherence, replace 
disposables such as masks, filters and hoses, manage side effects and maintain CPAP devices. (11, 14) 
CPAP adherence is problematic for a number of reasons such as mask fit, comfort, prescribed CPAP 
pressure tolerance, oral-nasal dryness, claustrophobia, abdominal bloating, psychological and social 
factors. A National Institute for Health and Clinical Excellence  technology appraisal reported adherence 
rates to CPAP therapy as 71% (range 64–83%) in the first year and 79% (range 68–90%) for those who 
persisted for more than 12 months. (15). However, the definition of CPAP adherence is inconsistent and 
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reports of CPAP adherence range from as low as 28% to more than 83% in more recent studies. (16, 17)  
Modern CPAP devices are now able to measure CPAP wear time and efficacy at effective pressure. (17)  
Low adherence to CPAP limits its therapeutic benefit, (17) and encouraging optimal – or at least 
adequate - CPAP use is a clinically important (6, 18) but an on-going time consuming problem globally.  
 
Telehealth to support clinical review of CPAP users has the potential to deliver effective and convenient 
care, (6, 19-23) with possible benefits in terms of therapy adherence, user satisfaction and reduced time 
taken from employment to attend a specialist sleep centre review. (6) For those living remotely 
telehealth can reduce travel and can have a significant environmental impact in terms of decreased 
carbon emissions. (20, 21, 23,) 
 
We aimed to systematically review the literature on the effectiveness, acceptability and health service 
resource implications of using telehealth (i.e. telemonitoring of CPAP usage data plus remote 




Our systematic review is registered with the PROSPERO International prospective register of systematic 
reviews [CRD42015019455]. (20) We did not make any changes to the protocol and we adhered to the 
procedures described in the Cochrane Handbook for systematic reviews of interventions, (24) and the 
PRISMA statement for reporting on systematic reviews. (25) An ethics checklist was submitted to the 





 Inclusion Criteria: 
Our PICOS inclusion/exclusion criteria are summarised in table 1.   We searched for randomised 
controlled trials (RCTs), quasi-RCTs and controlled clinical trials (CCTs) in those using CPAP therapy that 
compared teleconsultation combined with daily telemonitoring of CPAP data with face-to-face care.  
The interventions had to include both a consultation remote to the main healthcare facility (video or 
telephone consultation) and the facility for reviewing real-time telemonitoring of data from the CPAP 
device (defined as data transmitted and monitored by, or available to the reviewing clinical team via a 
web based platform at any time). We excluded telephone calls without telemonitoring and also 
telemonitoring without remote consultation. Our interest was in routine reviews of people established 




We searched eleven electronic databases; AMED; British Nursing Index; CINAHL; Cochrane Library; 
DARE; EMBASE; LILACS; MEDLINE; Web of Science and ZETOC. (Our detailed search strategy is given in 
supplemental file 1)  The bibliographies of included studies were scrutinised to identify possible 
additional studies and we also hand searched relevant sleep medicine and respiratory journals (Sleep 
Medicine, Journal of Clinical Sleep Medicine, Sleep, Sleep Medicine Reviews, Thorax, European 
Respiratory Journal, Breathe, BMJ Open Respiratory Research, Respiratory care, American Journal of 
Respiratory and Critical Care Medicine, Chest, European Respiratory Review, Respiratory Medicine,  
npjPrimary Care Respiratory Medicine). Search dates were not limited, but we only included studies 
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published in English as our resources did not permit translation.  The search was carried out in 
November 2015. 
 
 Selection of Studies: 
An initial sift and rejection of obviously unrelated abstracts was conducted by PM.  Titles and abstracts 
were then screened by PM with 25% checked by HP or BMcK (agreement 100%).  In order to ensure that 
we did not overlook potentially eligible trials we included all abstracts in which any form of telehealth 
and OSAHS and/or CPAP were explicitly mentioned. The full text of all potentially eligible studies were 
retrieved and independently assessed against the inclusion criteria by two reviewers (PM, and SL or HP); 
any disagreements were resolved by team discussion. The selection process was summarised using a 
PRISMA flow diagram (Figure 1). 
 
Quality assessment: 
The methodological quality of included studies was assessed (by PM and HP) using the Cochrane Risk of 
Bias tool, (24) and the Cochrane Effectiveness and Practice Organisation of Care (EPOC) guidelines. (26) 
The following seven domain-based parameters were used to assess bias: adequate sequence 
generation, allocation concealment; blinding of participants and personnel, blinding of outcomes, how 
incomplete outcome data were addressed, completeness of reporting and freedom from other sources 
of bias (supplemental file 2).  Included studies were given an overall risk of bias and any differences of 
opinion were resolved by discussion. 
 
Dealing with lack of information: 
If after full text assessment it was still unclear whether a study fulfilled the inclusion criteria, or if we 
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required clarification of any details relating to the intervention, study reporting or outcome data we 
contacted authors by email for further relevant information.  
  
Data extraction: 
We used a piloted data extraction sheet to extract characteristics of included studies under the 
headings; author and study year, risk of bias, number of participants,  country, setting, patient 
demographics, personnel, arrangements for remote consultation, telemonitoring of CPAP usage data, 
aspects of care addressed, duration and intensity of intervention, and care provided to the comparator 
groups (supplemental file 3).  
 
Outcomes: 
Primary outcomes were the proportion of patients that received a teleconsultation/telemonitoring 
review, and recorded adherence with CPAP therapy (by transmission of telemonitoring data). Secondary 
outcomes of interest were current symptom control (specifically sleepiness scores), patient and clinician 
acceptability and satisfaction with the teleconsultation/telemonitoring review, and health service 
resource use/cost compared to face-to-face care. 
 
 Data synthesis 
We expected that we would identify a limited number of eligible studies (based on our preliminary 
scoping work) with substantial heterogeneity so that meta-analysis would not be appropriate. We 






362 potentially relevant publications were identified, from which 17 full text articles were reviewed with 
12 being excluded (6, 19, 22, 23, 27-35) as they did not match our inclusion criteria  which is explained in 
(supplemental file 4).  Five papers fulfilled our inclusion criteria (table 2) Details of the selection process 
are given in Figure 1 PRISMA flow diagram.  Four studies were from North America, (3, 36-38) and one 
from Spain, (39) and all were based in community settings.   The five studies included a total of 269 
participants.  All the trials included telemonitoring of CPAP adherence; three utilised telephone 
consultations, (3, 37, 38) the other two utilised teleconferencing for remote consultations. (36, 39)  
 
Description of the study designs: 
Four of the included studies were RCTs; (3, 36-38) the other was a CCT. (39) The follow up period in the 
studies ranged from 1 to 6 months.  Four of the trials reported proportion of reviews achieved; outcome 
measures included CPAP adherence, (3, 36-38) Epworth sleepiness scale, (3, 37) patient/clinician 




The results of the methodological quality assessment are detailed in (supplemental file 2). One study 
was assessed as moderate risk of bias, (38) and four were at moderate-to-high risk of bias. (3, 36, 37, 39) 
The commonest sources of bias were lack of information regarding sequence generation, allocation 
concealment, completeness of reporting, no published study protocol, and the inability to blind study 




Description of the interventions: 
The characteristics of the included studies are described in detail (supplemental file 3), with a summary 
in (supplemental file 5).  All the interventions were conducted by trained nurses, respiratory or CPAP 
therapists and physicians.  The participants in all five studies had received face-to-face consultations to 
initiate CPAP therapy prior to entry to the trial.  
 
Telemonitoring of CPAP usage data: 
 Real time telemonitoring (via a modem) of CPAP adherence and efficacy was included in three studies. 
(3, 37, 39) Two studies used a home web-connected telemonitoring system (participant activated) with 
telephone support (36, 38).   In all studies, clinical personnel could access and monitor participants and 
intervene where indicated using predefined pathways.  
 
Teleconsultation for remote review: 
Telephone support by the clinical research staff was used to recommend appropriate action where 
necessary in four studies. (3, 36-38) Comma del Corral et al (39) used a video conference system at a 
remote site hospital with the central base Sleep Research Unit 80 Km away. Smith et al, used a home-
based telemedicine system with a built in modem and two way camera to allow the study nurses to 
deliver a structured 12-week CPAP education/support programme (36).  In order to mimic the materials 
and activities of the intervention group, the control group received a 12-week programme on a neutral 
health topic which discussed the importance of daily vitamin intake. This method was chosen to control 
for the potential influence of having telehealth in the home and to equalise the Hawthorne effect of 




Effectiveness of interventions: 
The findings of the studies are summarised in table 2, with further details in supplemental table 4, and 
synthesised below.  
 
 
Proportion reviewed:  
Two studies reported on number and/or duration of reviews reviewed. Fox et al found that an 
additional hour over the 3-month trial was spent with the telehealth patients compared with the usual 
care group. (3) In contrast, the teleconsultation/telemonitoring patients in Taylor et al’s study in new 
users of CPAP had fewer ‘walk-in visits’ than the usual care group. (38)  
 
Adherence to CPAP: 
In the study at moderate risk of bias (38) which recruited patients with a range of OSAHS severity, 
adherence to CPAP with teleconsultation/telemonitoring was similar to usual care even though the 
authors reported that problems with delivery of the telehealth (telephonic communication delays; and 
delays in delivery of equipment) may have diluted the intervention. Three lower quality studies reported 
improved CPAP adherence after the teleconsultation/telemonitoring intervention (3, 36, 37) although 
two were relatively small pilot studies.(36, 37) The controlled clinical trial reported adherence as 75% in 
the teleconsultation/telemonitoring intervention versus 85% in those who received usual care. (39) 
 
Control of Symptoms: 
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Two studies (both at moderate to high risk of bias) used the Epworth sleepiness score to record 
symptom control (3, 37) and the authors found no statistical difference between intervention and 
control groups.   One study also used the Functional Outcome of Sleep Questionnaire (FOSQ) and found 
no statistically significant differences between intervention and usual care group for any of the 
component measures of this tool. (37) Two studies did not measure symptom control. (36, 39) 
 
Patient/Clinician Acceptability/Satisfaction: 
All five studies reported on satisfaction with teleconsultation/telemonitoring verses face-face care. Four 
studies, using visual analogue scales (3, 39) or questionnaire ratings (37-39) found no difference in 
satisfaction between teleconsultation/telemonitoring and usual care. One study (36) (at moderate/high 
risk of bias) reported on patient acceptability and satisfaction of telemonitoring compared to the control 
group. The authors undertook thematic analysis of the free text comments on their satisfaction survey; 
100% of the surveys in teleconsultation/telemonitoring and 75% in usual care group rated the telehealth 
sessions positively (no statistical analysis reported); a key theme was that 
teleconsultation/telemonitoring was helpful in reinforcing the importance of CPAP adherence and they 
felt more supported with this intervention.  None of the studies reported on acceptability to clinicians.   
 
Costs of telehealth: 
Smith et al reported that the cost of delivering 14 teleconsultation/telemonitoring sessions for a single 
participant was $420 compared to $1,500 for face-face visits. (36) Comma del Corral reported on the 
overall teleconsultation/telemonitoring costs (which included diagnostic testing) but did not report the 





Summary of findings: 
The evidence base for the effectiveness of remote consultations with telemonitoring in the clinical 
review of those using CPAP therapy is limited to two small studies (36, 39) and three larger studies (3, 
37, 38), four of which were at moderate to high risk of bias(3, 36, 37, 39) and one at moderate risk if 
bias. (38)  These studies do not provide definitive evidence of effectiveness (in terms of adherence and 
symptom control) of teleconsultation/telemonitoring in CPAP users; however, there is no suggestion of 
any harms. The free text comments from a single study suggest that teleconsultation/telemonitoring 
was well received and perceived as being supportive. (36)  
 
Strengths and limitations: 
 
We searched a wide range of databases and kept our search strategies broad, but we may have missed 
some studies.  A key challenge for the review was the definition our definition of telehealth. We defined 
this for the purposes of this review as an intervention which included both remote consultation either 
by telephone or videoconferencing and also the facility for real-time telemonitoring of CPAP data 
adherence.  This meant we rejected interventions (for example) that used remote data on CPAP usage, 
but expected the patient to travel to follow-up consultations.  We recognise, however, that by including 
the dual requirements of the facility for real-time telemonitoring and remote consultations, we have 
excluded a number of important studies.   Our interest was in studies that facilitated CPAP clinical 
review and reduced the burden on the patient, and considered that not using remote consultations 
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obviated an important potential benefit of telehealth. Limited resources meant we were unable to 
arrange duplicate independent screening at all stages of the selection process, but we undertook 
duplicate screening of a proportion of the abstracts and after discussion achieved 100% agreement.  
Interpretation in the light of published literature: 
 
Telehealth is a rapidly developing field and since we undertook our searches, two potentially relevant 
studies have been published.   Fields et al is a prospective, parallel group pilot RCT, (40) which 
randomised 60 participants to telehealth (real time telemonitoring with telephone review) or usual 
(face-face) care. This study found no statistical between group differences in CPAP adherence, patient 
satisfaction, functional outcomes and dropout rates; though those randomised to telemedicine showed 
greater improvements in mental health scores.  Their formal and verbal feedback with all parts of the 
study were overwhelmingly positive.   Reinforcing the findings of this review, the authors concluded that 
larger scale trials are warranted in order to establish the benefits (or not) of telehealth for OSAHS. 
An RCT by Mufano et al (n=122) compared a telehealth programme (with real time telemonitoring and 
telephone support from sleep therapists triggered by responses to automated texts/e-mails) compared 
to usual care in people newly diagnosed with OSAHS. (41) Reflecting the findings of this review, they 
found no statistical between group difference in adherence to CPAP therapy or change in Epworth sleep 
score. However, the telehealth significantly reduced the time spent providing education and coaching 
making it a time-efficient option.  
A number of studies are not included in our systematic review because they did not meet our inclusion 
criteria which required both the facility for real-time telemonitoring and teleconsultation. (See 
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supplemental table 2 for details). We regarded both features as important in maximising the benefits of 
telehealth in OSAHS.  Nevertheless these studies may have some lessons of relevance to this review.  
Six studies did not have the facility for real-time tele-monitoring of CPAP, (6, 19, 22, 23, 29, 35) though 
two retrieved the data at the end of the study (6, 23) This may have reduced the potential for the 
clinicians to detect real time problems in remotely monitored participants such as poor/non adherence; 
poor mask fit/ leak, and treatment efficacy that could have resulted in clinician intervention to resolve 
any detected problems. Remote consultations were generally well-received, (6, 19, 23) and one trial 
found the teleconsultations to be cost effective (travel costs and lost work time were the most 
important sources of savings). (23)  
Adherence remains a major clinical issue for users of CPAP therapy.  Echoing the findings of this review, 
three of the teleconsultation RCTs showed no benefit in terms of adherence, (6, 19, 35) daytime 
sleepiness, (6) or quality of life. (6)  In contrast, Sparrow et al, tested a theoretically based motivational 
intervention delivered by telephone and showed a significant improvement in adherence, symptoms 
and functional status, (22) potentially relate to the theoretical approach to behaviour change   (42).   
Reasons for non-adherence are complex.   In an overview of the many factors that influence adherence 
to CPAP therapy, Shapiro et al (16) cite features of the CPAP device and side effects of treatment; as well 
as individual patient factors (such as clinical condition, family/home context, socio-economic status, 
personality, cognitive functioning), the attitude and communication skills of healthcare professionals, 
availability and efficiency of healthcare services, and national policy and funding of services (16).    More 
directly, the requirements of driving licensing agencies may have an important impact on adherence.. 
(7)   To be successful in promoting long-term adherence, sleep medicine clinicians need to monitor 
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adherence, educate and coach their patients, and reinforce this education at every clinical review. 
Access to real-time usage data is a tool to inform discussions about adherence 
Implications for research and future practice: 
Based on the results of the five trials included in this systematic review the evidence for remote 
teleconsultation with daily telemonitoring of CPAP usage in OSAHS is far from clear.  Well-designed, 
adequately powered studies are required to clarify the role of teleconsultation combined with real time 
telemonitoring in the clinical review of people using CPAP therapy. Reflecting the free-text comments in 
one of the studies, telemonitoring was perceived as reinforcing the importance of adherence, whilst 
remote consulting has the potential to facilitate convenient reviews especially for those living at a 
distance from sleep centres.   With the emergence of new technologies that enable remote 
teleconsultation and real time telemonitoring capability in-built into newer CPAP units, there is an 
opportunity for trials to build on the current evidence base and inform future practice in this area of 
specialised respiratory medicine.  
 
Conclusions: 
The combination of remote consulting and real-time telemonitoring in CPAP therapy users has the 
potential to offer equivalent care that is more convenient, reduces travel, and is thus environmentally 
friendly.   The technology to implement this model of sleep medicine service delivery is already available 
and being utilised in many health care settings, and driving research in this area.   The limited evidence 
to date from published trials that have included these interventions has not raised any safety concerns, 
but adequately powered trials at low risk of bias will be needed to establish whether telehealth 
(combining remote consultation and real time telemonitoring) is a clinically viable, acceptable and cost 
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Table 1: PICOS search strategy 
 
  Definitions 
Population People with a diagnosis of 
OSAHS on CPAP therapy 
Sleep apnoea is defined as a condition in which a 
person experiences repeated episodes of apnoea 
because of a narrowing or closure of the pharyngeal 
airway during sleep (9, 11) 
Intervention The application of telehealth 
to review people with a 
diagnosis of OSAHS and using 
CPAP 
This was defined as the use of telehealth to: 
 review patients remotely (e.g. telephone or 
video consultation) and 
 telemonitoring of CPAP usage  
We excluded telephone calls without telemonitoring 
and also telemonitoring without remote consultation 
Comparator Usual clinical care without 
telehealth  
Normally delivered face to face but may include some 
telephone calls (but without telemonitoring of CPAP 
data) 
Outcomes Primary outcome:  
Primary outcomes of interest 
were: 
 the proportion of patients 
who had received a 
telehealth review 
 adherence with 
prescribed CPAP therapy.  
Secondary outcomes:  
Secondary outcomes of 
interest included current 
control of symptoms of 
OSAHS, patient and clinician 
acceptability and satisfaction 
with the telehealth review, 
and health service resource 
use/cost implications 









CPAP adherence which  is typically defined as recorded 
use of CPAP therapy for > 4 hours per night however 




Clinical symptoms include validated measures of 
sleepiness, quality of sleep and quality of life 
 
Setting Any setting Typically the patient will be in the community, but the 
healthcare practitioner may be based in primary or 
secondary care.  























Figure 1 – Prisma Flow diagram  

























362 potentially relevant records identified 




























200 records after duplicates removed  
Initial screen to reject obviously ineligible abstracts  
 
139 Records excluded for not 
meeting the review criteria 
 
61 potentially relevant 
abstracts reviewed in detail  
 
44 papers excluded as: 
Mono component 9 
Editorial/opinions/reviews 21 
Observational studies 13 
Action plans/protocols 1 
Abstracts 2 






17 full-text articles 
assessed for eligibility 
12 full-text articles excluded: 
No remote monitoring 1 
No teleconsultation 7 
Non-randomisation in 
teleconsultation arm 3 












Table 2.  Summary of included studies  
Reference, 
Country, 


























Corral et al 
2013 [39] 
 Spain   
Mod/high risk 
RoB 
CCT. n= 16 
FU: 6m 
TH (video 
consultation  + 
telemonitoring 
of CPAP usage) 














vs UC 85% 
(significance 
not reported) 
Not measured Visual analogue 
scale used (1-
10) reported as 







n costs not 
reported for 
CPAP users 
TH to remote 
















+  telephone 
support if 
needed)   








80% male  
Compared with 
UC, more time 
was spent with 
the TH patients: 
TH: 210 mins 
(SD 42) vs UC: 
143  min (SD 
48) P < 0.0001 
Adherence 
greater in TH 
group: mean 
hours /night:  





- no significant 
between group 
differences (TH 
5.1 vs UC 5.2) 
 
Not measured Not measured TH may improve  
adherence to 
CPAP at initiation 
of therapy 





















use rate. TH 
(CPAP): 90%  vs 
Not measured Proportion 
rating service 
‘positively’ TH 
(CPAP) 100% vs 
TH (W-B) 75% 
(significance 
TH (CPAP) costs 
were less than 
TH (W-B) costs:  
TH (CPAP):  















with patients  v 
TH (W-B = well-
being advice) 
63yrs 
% male not 
reported 
TH (W-B): 44% 
(p = 0.033) 
not reported) (significance 


























Not measured  Non-significant 
trend to greater 
adherence   in 
TH group. 
Hours/night:4.1 
(SD 1.8) vs UC: 








9.2 (SD 6.6) vs 




CPAP higher in 
TH than UC 
group on score 
of 1 to 5 (4.8 vs  
4.3: P = 0.05) 









using CPAP  
Taylor et al 
2006 [38] 
US 




TH via Health 
Buddy + daily 
automated  












TH group had 
fewer ‘walk-in 
visits’ than the 
UC group 
(1/week vs 






4.29 (SD 2.15) 





Sleep Q  
(reported - no 
differences 
between  TM 







TH: 28.5 (SD 
3.1) vs UC 28.0 
(SD 3.5) p=0.43 
Not measured Very short 
follow-up (28 
days) 
Abbreviations: CCT- Controlled Clinical trial, N- Number, FU- Follow up, RCT- Randomised controlled trial, UC- Usual care, m= Month, OSAHS- Obstructive sleep apnoea /hypopnoea 
syndrome, US- United States, ROB- Risk of bias, CPAP- Continuous positive airway pressure 
